Guide Comp
Guide Comp
1. Guidelines for antimicrobial use in the treatment of dogs and cats compiled on
commission from the Board of the Swedish Veterinary Society. The General Assembly
of the Swedish Veterinary Association adopted these as their policy in October 2002.
2. The FECAVA (Federation of European Companion Animal Veterinary Associations)
guidelines, October 2014.
3. Consultation with New Zealand veterinary specialists to combine the data from
the above documents and adapt them for New Zealand conditions and diseases.
The intention is that this policy should be used as a general Antimicrobial – a drug, chemical, or other substance that either
guide when choosing treatment for dogs and cats. This can kills or slows the growth of microbes. Substances that are
sometimes mean either to refrain from treatment altogether considered antimicrobials include surface disinfectants, antibiotics,
or alternatively to choose a treatment that does not include parasiticides, anti-fungal and anti-viral agents (MPI definition).
antibiotics. The main aim is that the chosen treatments are as
effective as possible and that any undesirable side effects are
Acknowledgments
kept to a minimum. These guidelines have been formulated by the Antimicrobial Working Group
appointed by NZVA:
The policy can be used both for clinical practice, as well as for Professor Paul Chambers BVSc Bristol, DVA, PhD
educational purposes. Dr Isobel Gibson DVM Guelph, DVSc, DiplACVP
The document is divided into four main parts: Dr Kristen Manson BVSc Massey MANZCVS (Veterinary Pharmacology)
Dr Andrew Millar BVSc Massey MANZCVS (Veterinary Pharmacology)
1. Antimicrobial policy.
Dr Dennis Scott BVSc Massey MANZCVS (Veterinary Pharmacology)
2. The perioperative use of antibiotics. The guidelines have been approved by the Companion Animal Veterinarians
3. Guidelines for treatment based on disease-oriented Branch of the NZVA.
treatment. Peer review was carried out by:
4. General information concerning antimicrobial alternatives. Dr Nick Cave BVSc Massey, MACVSc, MVSc, DiplACVN, PhD, Senior
Lecturer in Small Animal Medicine, Massey University
The main document is designed as a reference document Professor Paul Chambers BVSc Bristol, DVA, PhD Senior Lecturer
with a summary in wall chart form to be utilised in in Veterinary Pharmacology, Massey University
consultation rooms and surgeries. Dr Allan Bell BVSc Massey, MACVSc, FACVSc, Registered specialist
in Veterinary Dermatology
Note: The tables shown provide examples and should not be
Dr Craig Irving BVSc Massey 1970, MACVSc, CertVet Ophthal, Registered
considered to be comprehensive. Regional data on resistance
specialist in Veterinary Ophthalmology
have to be taken into consideration. Use an antibiotic with
The project was carried out at the behest of, and under the supervision of the
known bioavailability at target site, and use as narrow Antimicrobial Strategic Group of NZVA comprised of:
spectrum a drug as possible.
Dr Mark Bryan BVMS Glasgow, MACVSc (Epidemiology), MVS (Hons)
Professor Nigel French BVSc Bristol, MSc, PhD, DLSHTM
Definitions Dr Eric Hillerton BSc PhD Adjunct Professor in Dairy Systems at Massey
University, Member Royal Entomological Society
Antibiotic – a medicine that kills bacteria or inhibits their
growth in the body. It includes natural substances (e.g. Dr Callum Irvine BVSc Melbourne (Hons)
penicillin), semisynthetic substances (e.g. ampicillin) and Dr Steve Merchant BVSc Massey (Dist)
totally synthetic substances (e.g. enrofloxacin). Dr Dennis Scott BVSc Massey MANZCVS (Veterinary Pharmacology)
Resistance development can be reduced by the responsible antibiotics). Local treatment should be used where possible.
use of antimicrobials, good hygiene, and active infection Any effect on the normal flora can also be minimised if the
control. Active advice to animal owners on, for example, course of treatment is kept as short as possible.
hygiene and vaccination also plays an important part.
Drugs of last resort for serious infections in people should not
The objective of this document has been to produce a guide be used in animals. Third or fourth generation cephalosporins
that can be used when deciding upon a course of treatment should only be used in situations where their use is considered of
and it is written for current New Zealand conditions and the utmost importance to the animal’s welfare, and where there
practices. Sometimes the right choice can be to refrain from is a sound basis to suspect that other treatments will not work.
antimicrobial therapy altogether and instead to simply wait
and see, or alternatively choose another treatment.
Antibiotic treatment is normally only indicated if: Core principles
1. Consider the impact of antibiotic use on the animal, its
• there is bacterial infection
owner and other people, and the environment.
OR
2. Animals should receive antibiotics only when there is a
• there is sufficient reason to suspect that a bacterial susceptible bacterial infection, antibiotics are required
infection is present to maintain their health and welfare, and when no other
and treatment will work.
• the infection is not likely to resolve without antibiotic 3. When antibiotics are used, dose rates and regimes should
therapy. be designed for maximal efficacy and to limit re-treatment.
4. There are antibiotics considered so important in human
Measures to prevent infection should be used where possible
and if there is a non-antibiotic treatment which is likely to be medicine that they should not be used as first line
effective, this should be used in preference to antibiotics. treatment, and only used where no other treatment will
work.
Antibiotics prescribed “just in case” there is a bacterial infection
is never acceptable. Prophylactic antibiotic treatment can be 5. There will be a reduction in selection pressure for
justified in a few specific surgical procedures, where the risk for antimicrobial resistance if a smaller total amount of
bacterial infection is high or where an infection can drastically antibiotics are used in veterinary and human medicine.
worsen the prognosis. Prophylactic use of antibiotics should
never be used to cover for poor hygiene.
Antibiotic classification
Lifelong antibiotic treatment of chronic or continually recurring
General guidelines classifying antimicrobials according to
conditions is not compatible with good veterinary practice.
a three tier (traffic light) system is an example of a type of
This also applies to prolonged treatments with a low dose (less
system that might be employed.
than the therapeutic dose) or so-called pulse dosing.
Culture and sensitivity testing should be used to guide the
When possible, the infectious agent should be cultured
choice of drugs whenever possible.
and identified. This is especially important in cases of therapeutic
failure, relapse, and when antimicrobial resistance is suspected. Note: First line therapy represents the first choice for empirical
Samples should always be taken from postoperative infections. therapy.
The risk of antibiotic resistance should always be considered Narrow-spectrum antibiotics should be used in preference to
when choosing an antibiotic. This means that the drug and the broad-spectrum drugs when possible.
route of administration should be chosen so that the animal’s
Topical therapy should be used in preference to systemic
normal flora is affected as little as possible (narrow-spectrum
therapy whenever appropriate.
Refinement Review
Continuously evaluate prescribing practices and therapeutic A stewardship plan is a ‘living document’ and will be subject
plans, based on: to periodic (at least annual) review to ensure objectives
1. Response to treatment are met.
2. Previous similar cases 1. Animal health and welfare outcomes remain top priority
3. Published clinical studies and monitored to ensure they are achieved.
4. Local and published resistance data 2. Audit of compliance should be undertaken internally
and by independent bodies.
3. Reduction and replacement strategies should be monitored
Replacement
through measurement of animal daily doses (ADD) used.
Selection pressure can be reduced by using non-antimicrobial
alternatives where there is evidence of efficacy. 4. Susceptibility surveillance should be undertaken as appropriate
to ensure appropriate selection of antimicrobials, maximise
efficacy and monitor resistance in target pathogens.
5. Investigation of strategies that can be employed to
improve stewardship of antimicrobials within the practice
should occur on an on-going basis.
3. Guidelines
required – treating new episodes of pyoderma as clinical
signs arose.
However this technique is better suited to referral centres and
Common Surface pyoderma Superficial pyoderma Deep pyoderma Wound/soft tissue Cat bite abscesses Otitis externa
conditions (microbial (bacterial folliculitis, (furunculosis, infection
overgrowth, fold impetigo) cellulitis)
pyoderma, acute
moist dermatitis)
Cytology and
culture
impression smears
from impression + + + of ear swabs
smears, tape strips + obtained after
preliminary cleaning
+
from pustule following biopsy
(if possible or by aspiration for surveillance
(not from surface of surgical site
exudate) infections or if not relevant due to
complications/ topical therapy
suspicion of multi-
resistant bacteria (e.g.
MRSP, MRSA, ESBL)
Likely pathogen Staphylococcus Staphylococcus Staphylococcus Variable Variable Cocci (mainly
pseudintermedius pseudintermedius pseudintermedius Staphylococcus
(Malassezia pseudintermedius),
sometimes involved) rods (mainly
Pseudomonas), and/
or yeasts, (Malassezia)
Empirical anti- Clindamycin or Cephalexin while Cleansing and Antiseptics often
microbial choice Cephalexin or TMPS debridement sufficient
coupled with
modern wound Topical treatment
dressings are often e.g. cocci use fusidic
Pending acid, rods use
sufficient
Amoxicillin when polymyxin B, yeasts
Systemic therapy indicated use miconazole
based on
may be indicated in
severe tissue damage
and/or fever
Remarks on therapy Topical therapy Therapy alone Always combine Topical antimicrobials Prior cleansing is
with antimicrobial (e.g. chlorhexidine) with topical therapy are usually not essential
shampoos, lotions, if infection is mild. (e.g. chlorhexidine recommended with
spray gels, creams etc shampoo). granulating wounds Use gluco-corticoid
Treat for seven days to reduce swelling
beyond clinical Treat for two weeks If as above always Drainage, copious and inflammation
resolution beyond clinical take sample after irrigation, and
resolution wound cleaning Underlying causes
debridement of
must be investigated
necrotic tissue
and resolved
R if persistent Third generation
Systemic therapy is
cephalosporins e.g.
not relevant
cefovecin, should
NOT be used for cat
bite abscesses
Reference key R
+ +
pending pending
If signs of systemic infection see sepsis
Remarks on therapy Amoxicillin three times daily
Reference key R
Amoxicillin-clav
three times daily
Amoxicillin-clav three times
daily
Reference key R
Remarks on therapy
For Salmonella,
Campylobacter and of wound of aspirate or biopsy of aspirate obtained by abdomino-centesis (both aerobic and
toxigenic clostridia cavity if severe anaerobic incubation)
tissue damage
and/or fever
(after wounds
cleaning)
Likely pathogen Mainly viruses (or Variable Unknown or variable Variable
parasites in young
animals faecal sample
for parasitology on
suspicion)
Empirical Self-limiting, Doxycycline or Fluoro-quinolones and penicillin G or amoxicillin or ampicillin IV
anti-microbial cephalexin while
choice
pending
+
If signs of systemic
infection see sepsis
In severe tissue
damage and/or
fever use TMPS
while pending
Remarks on
therapy
Drainage
Reference key R
+ +
Likely pathogen Rarely bacterial in dogs, Primary ulcers rarely bacterial. Rarely bacterial Staphylococci, Streptococci
Chlamydophila felis and
Mycoplasma in cats.
Empirical anti-microbial Fusidic acid topically in dogs, Primary: fusidic acid Fusidic acid
choice tetracyclines in cats
Deep stromal: tetracyclines
Melting: fluoroquinolones
Reference key R
pending
Remarks on therapy Before isolation and
sensitivity testing
incubate sample in
blood culture medium
Amoxicillin or ampicillin preferably as
for 24 hours at 37° C.
a CRI (constant rate infusion) or three
times daily
YES NO
Choose an
antimicrobial
If indicated, change treatment
based on
according to laboratory results and if
laboratory
possible to an antimicrobial with the
findings, current
narrowest spectrum
recommendation
s and scientific
literature
If there is a
poor response to
therapy, review
your diagnosis
and therapeutic
plan